177 related articles for article (PubMed ID: 2142393)
21. Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology.
Rodríguez-Burford C; Steele VE; Anderson AS; Stockard CR; Weiss HL; Eto I; Johanning GL; Grizzle WE; Grubbs CJ
Nutr Cancer; 2002; 43(1):67-75. PubMed ID: 12467137
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of DNA synthesis by retinyl acetate during chemically induced mammary carcinogenesis.
Mehta RG; Moon RC
Cancer Res; 1980 Apr; 40(4):1109-11. PubMed ID: 6766804
[TBL] [Abstract][Full Text] [Related]
24. Modulatory influences of tamoxifen, tocopherol, retinyl acetate, aminoglutethimide, ergocryptine and selenium on DMBA-induced initiation of mammary carcinogenesis in rats.
Rao AR; Hussain SP; Jannu LN; Kumari MV; Aradhana
Indian J Exp Biol; 1990 May; 28(5):409-16. PubMed ID: 2119338
[TBL] [Abstract][Full Text] [Related]
25. Modulation of DNA damage by vitamin A in developing Sprague-Dawley rats.
Bolognesi C; Ognio E; Ferreri-Santi L; Rossi L
Anticancer Res; 1992; 12(5):1587-91. PubMed ID: 1444226
[TBL] [Abstract][Full Text] [Related]
26. Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer.
Shealy YF; Frye JL; Riordan JM; Hill DL; McPhillips M; Wille JJ; Sani BP; Kalin JR; Eto I; Grubbs CJ
Anticancer Drug Des; 1997 Jan; 12(1):15-33. PubMed ID: 9051111
[TBL] [Abstract][Full Text] [Related]
27. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?
Lubet RA; Heckman BM; De Flora SL; Steele VE; Crowell JA; Juliana MM; Grubbs CJ
Oncol Rep; 2011 Sep; 26(3):731-6. PubMed ID: 21617870
[TBL] [Abstract][Full Text] [Related]
28. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas.
Alshafie GA; Harris RE; Robertson FM; Parrett ML; Ross M; Abou-Issa H
Anticancer Res; 1999; 19(4B):3031-6. PubMed ID: 10652588
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis.
Abou-Issa H; Curley RW; Alshafie GA; Weiss KL; Clagett-Dame M; Chapman JS; Mershon SM
Anticancer Res; 2001; 21(6A):3839-44. PubMed ID: 11911255
[TBL] [Abstract][Full Text] [Related]
30. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
31. Influence of caffeine consumption on 7,12-dimethylbenz(a)anthracene-induced mammary gland tumorigenesis in female rats fed a chemically defined diet containing standard and high levels of unsaturated fat.
Welsch CW; DeHoog JV
Cancer Res; 1988 Apr; 48(8):2074-7. PubMed ID: 3127045
[TBL] [Abstract][Full Text] [Related]
32. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.
Gandilhon P; Melancon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of mammary cancer by retinyl methyl ether.
Grubbs CJ; Moon RC; Sporn MB; Newton DL
Cancer Res; 1977 Feb; 37(2):599-602. PubMed ID: 401683
[TBL] [Abstract][Full Text] [Related]
34. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat.
Isaacs JT
Cancer Res; 1986 Aug; 46(8):3958-63. PubMed ID: 3089584
[TBL] [Abstract][Full Text] [Related]
35. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
37. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats.
Ratko TA; Detrisac CJ; Dinger NM; Thomas CF; Kelloff GJ; Moon RC
Cancer Res; 1989 Aug; 49(16):4472-6. PubMed ID: 2525951
[TBL] [Abstract][Full Text] [Related]
38. Melatonin and retinyl acetate as chemopreventives in DMBA-induced mammary carcinogenesis in female Sprague-Dawley rats.
Ahlersová E; Ahlers I; Kubatka P; Bojková B; Môciková K; Gajdosová S; Onderková HM
Folia Biol (Praha); 2000; 46(2):69-72. PubMed ID: 10813093
[TBL] [Abstract][Full Text] [Related]
39. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.
Grubbs CJ; Steele VE; Casebolt T; Juliana MM; Eto I; Whitaker LM; Dragnev KH; Kelloff GJ; Lubet RL
Anticancer Res; 1995; 15(3):709-16. PubMed ID: 7645947
[TBL] [Abstract][Full Text] [Related]
40. Effect of short-term feeding of sodium selenite on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in the rat.
Thompson HJ; Meeker LD; Becci PJ; Kokoska S
Cancer Res; 1982 Dec; 42(12):4954-8. PubMed ID: 6814747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
